4.6 Article

Studies of Metabolic Phenotypic Correlates of 15 Obesity Associated Gene Variants

期刊

PLOS ONE
卷 6, 期 9, 页码 -

出版社

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0023531

关键词

-

资金

  1. Novo Nordisk Foundation
  2. Lundbeck Foundation Centre
  3. Danish Health Research Council
  4. FOOD Study Group/the Danish Ministry of Food, Agriculture and Fisheries and Ministry of Family and Consumer Affairs [2101-05-0044]
  5. Novo Nordisk A/S Research & Development Corporate Research Affairs
  6. Danish Ministry of Science Technology and Innovation
  7. Faculty of Health Sciences of Aarhus University
  8. Danish Clinical Intervention Research Academy
  9. Danish Diabetes Association
  10. European Commission [LSHM-CT-2005-018734]
  11. The Danish Obesity Research centre (DanORC)
  12. Danish Council for Strategic Research [2101-06-0005]
  13. Danish Research Counsil
  14. Danish Centre for Health Technology Assessment
  15. Novo Nordisk Inc.
  16. Research Foundation of Copenhagen County
  17. Ministry of Internal Affaires and Health
  18. Danish Heart Foundation
  19. Danish Pharmaceutical Association
  20. Augustinus Foundation
  21. Ib Henriksen Foundation
  22. Becket Foundation
  23. National Health Services in the counties of Copenhagen, Aarhus, Ringkobing, Ribe
  24. South Jutland in Denmark
  25. Danish Research Foundation for General Practice
  26. Danish Centre for Evaluation and Health Technology Assessment
  27. National Board of Health
  28. Danish Medical Research Council
  29. Aarhus University Research Foundation
  30. Novo Nordisk A/S
  31. Novo Nordisk Scandinavia AB, ASTRA Denmark
  32. Pfizer Denmark
  33. GlaxoSmithKline Pharma Denmark
  34. SERVIER Denmark A/S
  35. HemoCue Denmark A/S

向作者/读者索取更多资源

Aims: Genome-wide association studies have identified novel BMI/obesity associated susceptibility loci. The purpose of this study is to determine associations with overweight, obesity, morbid obesity and/or general adiposity in a Danish population. Moreover, we want to investigate if these loci associate with type 2 diabetes and to elucidate potential underlying metabolic mechanisms. Methods: 15 gene variants in 14 loci including TMEM18 (rs7561317), SH2B1 (rs7498665), KCTD15 (rs29941), NEGR1 (rs2568958), ETV5 (rs7647305), BDNF (rs4923461, rs925946), SEC16B (rs10913469), FAIM2 (rs7138803), GNPDA2 (rs10938397), MTCH2 (rs10838738), BAT2 (rs2260000), NPC1 (rs1805081), MAF (rs1424233), and PTER (rs10508503) were genotyped in 18,014 middle-aged Danes. Results: Five of the 15 gene variants associated with overweight, obesity and/or morbid obesity. Per allele ORs ranged from 1.15-1.20 for overweight, 1.10-1.25 for obesity, and 1.41-1.46 for morbid obesity. Five of the 15 variants moreover associated with increased measures of adiposity. BDNF rs4923461 displayed a borderline BMI-dependent protective effect on type 2 diabetes (0.87 (0.78-0.96, p = 0.008)), whereas SH2B1 rs7498665 associated with nominally BMI-independent increased risk of type 2 diabetes (1.16 (1.07-1.27, p = 7.8x10(-4))). Conclusions: Associations with overweight and/or obesity and measures of obesity were confirmed for seven out of the 15 gene variants. The obesity risk allele of BDNF rs4923461 protected against type 2 diabetes, which could suggest neuronal and peripheral distinctive ways of actions for the protein. SH2B1 rs7498665 associated with type 2 diabetes independently of BMI.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据